A b-catenin/T cell factor-dependent transcriptional program is critical during cutaneous wound repair for the regulation of scar size; however, the relative contribution of b-catenin activity and function in specific cell types in the granulation tissue during the healing process is unknown. Here, cell lineage tracing revealed that cells in which b-catenin is transcriptionally active express a gene profile that is characteristic of the myeloid lineage. Mice harboring a macrophage-specific deletion of the gene encoding b-catenin exhibited insufficient skin wound healing due to macrophage-specific defects in migration, adhesion to fibroblasts, and ability to produce TGF-b1. In irradiated mice, only macrophages expressing b-catenin were able to rescue wound-healing deficiency. Evaluation of scar tissue collected from patients with hypertrophic and normal scars revealed a correlation between the number of macrophages within the wound, b-catenin levels, and cellularity. Our data indicate that b-catenin regulates myeloid cell motility and adhesion and that b-cateninmediated macrophage motility contributes to the number of mesenchymal cells and ultimate scar size following cutaneous injury.
factors (Tcfs) in the nucleus forms a transcriptional activation complex that induces the expression of cell type-specific target genes, ultimately regulating the size of the scar remaining after wound repair (13) . We previously showed that a subset of cells in the wound granulation tissue exhibit increased β-catenin/ Tcf-mediated transcriptional activity, which returns to baseline following the proliferative phase (5) . However, the relative contribution of β-catenin signaling in specific cell types in wound repair is not completely elucidated.
Myeloid cells can exist as circulating monocytes and as tissue macrophages that contribute to hemostasis, inflammation, and acquired immunity (14, 15) . Macrophage cells play a critical role in wound repair, since in their absence there is a near-complete lack of accumulation of granulation tissue (14) (15) (16) (17) (18) (19) (20) . However, the regulation and function of myeloid lineage cells during the repair process are not known. Here, we show that wound granulation tissue cells with active β-catenin/Tcf transcription express marker genes for macrophages. Using genetically modified mice and cell lineage-tracing studies, we show that β-catenin in macrophages is essential for normal wound repair by regulating macrophage cell motility and adhesion, ultimately controlling the recruitment of the critical cells responsible for normal repair into the wound bed.
Results

Genes that are characteristically expressed by macrophages are upregulated in Tcf transcriptionally active cells during skin healing.
To identify the cell types in which β-catenin/Tcf signaling is activated during skin wound healing, we examined the repair of full-thickness wounds in Tcf reporter mice (5, 21) . In these mice, Tcf-mediated transcription activated the expression of lacZ, which we detected in 7-day-old wound granulation tissue using β-gal staining (Figure 1A ). Cells were dissociated from the granulation tissue and sorted into β-gal-positive and -negative cells by FACS using fluorescein di-β-D-galactopyranoside (FDG) (22) . Comparison of gene expression between both populations using the Affymetrix mouse 1.0 ST gene array analyzed with Ingenuity pathway analysis (23) identified the activation of macrophage markers and pathways in the β-gal-positive cell population (Supplemental Table 1 , Gene Expression Omnibus [GEO] database, GEO GSE30913; supplemental material available online with this article; doi:10.1172/ JCI62059DS1). Real-time PCR confirmed that cells with active β-catenin/Tcf signaling exhibited markedly higher expression of the macrophage markers F4/80, CD281, and CD204 compared with the Tcf-inactive population ( Figure 1B) .
Lysozyme-expressing progeny cells account for 18% of cells in the healing dermis and are active for β-catenin-mediated Tcf-dependent signaling.
To further examine the specific contribution of macrophages to wound repair, we generated mice that permanently express enhanced yellow fluorescent protein (EYFP) under control of the lysozyme (Lysz) promoter (Lysz-Cre ROSA-EYFP mice, Supplemental Figure 1 and Supplemental Figure 2 ). Lysozyme is expressed in myeloid cells, including monocytes and macrophages (24) . The skin of the unwounded Lysz-Cre ROSA-EYFP mice contained only a small proportion (2.1 ± 0.95%, 95% CI) of EYFP-positive cells. In the intact skin, EYFP-positive cells were almost all positive for the macrophage marker F4/80 ( Figure 1C) , showing the specificity of the EYFP in identifying myeloid lineage cells. The EYFP-positive cells in the intact skin rarely exhibited nuclear β-catenin staining (8 ± 7% of cells, Figure 1D ). In contrast, 69 ± 17% of EYFP-positive cells in the granulation tissue of healing wounds exhibited nuclear β-catenin staining ( Figure 1E ). Next, we crossed Lysz-Cre ROSA-EYFP mice with Tcf LacZ reporter mice (Lysz-Cre ROSA-EYFP Tcf, Supplemental Figure 1 ). Quantification of 7-day-old wound granulation tissue for cells double-positive for EYFP and β-gal expression demonstrated that 75 ± 18% of myeloid cells or their progeny had active β-catenin/Tcf signaling ( Figure 1F ). EYFP-positive cells were substantially enriched in the granulation tissue as compared with those see in the neighboring intact skin ( Figure  2 , A-C). Analysis of cells from the wounds using flow cytometry showed that EYFP-positive cells accounted for 18 ± 6% of all cells in the granulation tissue ( Figure 2 , D and E). EYFP-positive cells persisted at 4 weeks after wounding and accounted for 11 ± 6% of the cells in the scar tissue at this later time point (Supplemental Figure 5 ). Thus, β-catenin-mediated Tcf-dependent signaling was active in the majority of myeloid lineage cells present during proliferative phase of dermal skin, and these cell accounted for a substantial proportion of cells present in early wound repair.
β-Catenin in myeloid lineage cells has an essential role during skin healing. To investigate the functional role of β-catenin in myeloid cells, we crossed Lysz-Cre ROSA-EYFP mice with mice expressing the Catnb tm2KEM allele (Lysz-Cre Catnb tm2KEM ROSA-EYFP mice; Supplemental Figure 3 ). In these mice, β-catenin was specifically eliminated in the EYFP-positive myeloid cells. In contrast to normally healing, full-thickness cutaneous wounds in control Lysz-Cre ROSA-EYFP mice ( Figure 3A) , wounds in mice with the myeloid-specific β-catenin knock down lacked closure of the wound 1 week after injury, as demonstrated by incomplete converged keratinocytes and a near-complete lack of granulation tissue at this time point ( Figure 3B , quantified in Figure 3 , C and D, and in Supplemental Figure 3D ). This wound-healing phenotype is reminiscent of the phenotype observed in mice lacking macrophages (16, 17) . Since recombination efficiency may not have been complete, we examined whether there was a relationship between recombination efficiency and the wound phenotype. Since wounds from mice in which macrophages lacked β-catenin showed very little granulation tissue, we examined recombination efficiency in macrophages in the bone marrow. There was a negative correlation between the extent of recombination (percentage of bone marrow-derived EYFP-positive macrophages in Lysz-Cre Catnb tm2KEM ROSA-EYFP mice) and the number of cells in the granulation tissue (r = -0.865, Pearson's correlation, P value < 0.014) ( Figure 3E ). In mice lacking β-catenin in macrophages, the scar was immature and retained proliferation-phase characteristics 4 weeks after wounding. Aniline blue staining demonstrated lower levels of collagen and hypercellularity in wounds of Lysz-Cre Catnb tm2KEM ROSA-EYFP mice compared with levels in control mice. Using a collagen deposition score, the control mice were found to have more collagen deposition in their wounds (9.8 ± 3.4 in control mice versus 4.6 ± 2.9 in Lysz-Cre Catnb tm2KEM ROSA-EYFP mice) 4 weeks after wounding. Mice lacking β-catenin in macrophages showed defective cutaneous repair kinetics and deficient ultimate healing.
Macrophages lacking β-catenin cannot rescue deficient skin healing. To determine the function of β-catenin in macrophages during pathologic wound repair, we examined healing in the mice that were irradiated at sublethal doses (2.6 Gy 24 hours before wounding). Wounds in these mice lacked macrophages and had a phenotype reminiscent of that seen in macrophage-deficient mice (refs. 25, 26, and Figure 4A , magnified in Figure 4D ). Control or β-catenin-deficient macrophages harvested from bone marrow were applied to the wounds of irradiated mice. Control macrophages, which can be detected by red fluorescent protein (RFP) expression, substantially improved skin wound healing and increased the number of cells present in the 7-day-old wound granulation tissue ( Figure 4B , magnified in E). Flow cytometry of cells from the granulation tissue of the irradiated mice showed RFP + cells in the wounds ( Figure 4H ). In contrast, β-catenin-deficient macro- phages were not able to restore normal healing of the wounds that were devoid of granulation tissue cells ( Figure 4C , magnified in Figure 4F ; total cell number is quantified in Figure 4I ). This raises the possibility that macrophages lacking β-catenin are deficient in their ability to migrate to the healing wound ( Figure 4G ).
β-Catenin regulates genes implicated in cell migration and adhesion in macrophages. Since β-catenin regulates gene expression, we performed gene profiling using the Affymetrix mouse 1.0 ST cDNA gene array to determine the function of β-catenin in macrophage cells. Compared with control macrophages, β-catenin-deficient macrophages showed decreased expression of numerous genes with functions attributed to migration and adhesion, including members of the cadherin, integrin, and a disintegrin and metalloproteinase (ADAM) gene families (Gene Expression Omnibus database, GEO GSE52163) (Supplemental Table 2 ). Cadherins and catenins are important for macrophage cell contact (27) (28) (29) (30) (31) , whereas ADAMs and integrins are important for macrophage cell migration (32) . More than 50% of ADAM and integrin gene family members showed lower expression levels in macrophages from Lysz-Cre Catnb tm2KEM mice compared with those observed in control macrophages (Supplemental Table 3 and Supplemental Table 4 ).
β-Catenin regulates macrophage cell adhesion to fibroblasts. The data from gene expression profiling and from the treatment of irradiated wounds suggest that that β-catenin regulates macrophage cell migration and/or adhesion. Thus, we next examined the characteristics of macrophage adhesion to fibroblastic cells. Macrophages obtained from Lysz-Cre Catnb tm2KEM ROSA-EYFP and control Catnb tm2KEM ROSA-EYFP mouse bone marrow were seeded onto monolayers of cultured fibroblasts that do not express the conditional β-catenin allele. Macrophages deficient in β-catenin showed a smaller number of cells adhering to fibroblasts (80 ± 8% versus 57 ± 16%) compared with those seen in control macrophages ( Figure 5 ). Scanning electron microscopy showed that β-catenindeficient macrophages formed fewer (24 ± 6% vs. 14 ± 7%) and shorter pseudopod projections when adhering to the fibroblast layer (P < 0.043) ( Figure 5E ) compared with those in control macrophages ( Figure 5B ). Since cadherins and catenins are important for macrophage cell contact (27-31), we examined the expression of α-catenin and cadherin-2 (N-cadherin). Quantitative PCR demonstrated a significant decrease in α-catenin and cadherin-2 expression in macrophages lacking β-catenin compared with macrophages from control littermates ( Figure 5H ). β-catenin plays a role in macrophage adhesion to fibroblasts, and this adhesion is likely important for the ability of reparative myeloid lineage cells to be retained in the wound granulation tissue.
Macrophages lacking β-catenin are impaired in their ability to migrate. To determine the role of β-catenin in macrophage motility, we used an in vitro monolayer scratch assay. Macrophages lacking β-catenin demonstrated less migration into the cell-denuded gap than did control macrophages ( Figure 6, A and B) . Using a Boyden chamber Transwell migration assay, we measured the number of macrophages migrating through a porous membrane to reach a monolayer of murine fibroblasts ( Figure 6C ) or a fibroblast-free cell culture surface ( Figure 6D ). In both situations, the number of β-catenin-deficient macrophages migrating across the membrane was significantly lower than the number of control macrophages.
β-Catenin regulates TGF-β1 production in macrophages during wound repair. Macrophages during wound repair liberate TGF-β1 (15, (33) (34) (35) . To evaluate whether β-catenin signaling affects active TGF-β1 production by macrophages, we compared macrophages obtained from the bone marrow of Lysz-Cre Catnb tm2KEM ROSA-EYFP mice with those from control Catnb tm2KEM ROSA-EYFP. β-catenin-deficient macrophages displayed significantly lower levels of TGF-β1 compared with control macrophages ( Figure 7A) . Using a reporter cell line that produces luciferase under the control of a PAI-1 promoter, we found that conditioned media from β-catenin-deficient macrophages induced less TGF-β1 signaling in fibroblasts compared with that in the media from control macrophages. Direct cocultures with fibroblasts and β-catenin-deficient macrophages exhibited substantially lower active TGF-β1 signaling compared with that in control macrophages, as detected by the number of pSmad2-positive cells in fibroblasts ( Figure 7 , B and C). The percentage of Ki67-positive proliferating fibroblasts was also lower in coculture with β-catenin-deficient macrophages than with control macrophages (Figure 7 , D and E). To determine whether this decrease in TGF-β1 signaling by β-catenin macrophages plays a functional role in the defective wound repair, we treated wounds from β-catenin-deficient mice with recombinant TGF-β1. Treatment with TGF-β1 increased the number of cells in the wound granulation tissue ( Figure 7F , P < 0.01) and resulted in a healing phenotype that is closer to that observed in the normal healing situation (Figure 7 , G and H).
β-Catenin is required for a subpopulation of lysozyme-expressing cells to attain a mesenchymal cell-like phenotype. Macrophages are thought to have the capacity to attain cytological features similar to those in mesenchymal cells (36) (37) (38) (39) (40) (41) . Such a phenotype might be related to their migratory capacity, as is the case in tumor cells during migration (8, 32, 42) . EYFP-positive cells in 1-week-old wounds were stained for fibroblast activation protein (FAP) (43); a myofibroblast marker, α-smooth muscle actin (α-SMA) (44) ; and the macrophage marker F4/80 (45) . The majority of EYFP-positive cells (57 ± 9%) expressed F4/80 (Supplemental Figure 4A) . However, 33 ± 12% of EYFP-positive cells expressed FAP, and 24 ± 9% of EYFP-positive cells expressed α-SMA (Supplemental Figure 4 , B and C). To determine whether these findings were related to macrophage clearance of mesenchymal cells or to the ability of macrophages themselves to achieve a fibroblastic phenotype, we examined macrophages in vitro in the absence of mesenchymal cells. A subpopulation of macrophages from Lyzs-Cre ROSA-EYFP mice were grown in cell culture, deprived of macrophage differentiation medium, and instead grown in DMEM. These cells developed a phenotype similar to that of fibroblasts (Supplemental role in mediating the development of this fibroblastic phenotype, once deprived of macrophage differentiation medium, macrophages from Lyzs-Cre Catnb tm2KEM ROSA-EYFP and Lyzs-Cre ROSA-EYFP mice were grown under identical cell culture conditions. We found that macrophages lacking β-catenin did not develop a fibroblast-like phenotype (Supplemental Figure 6 , E and F) and that fibro blasts from these same mice exposed to macrophagespecific media did not express macrophage markers or EYFP in vitro, suggesting that the expression of these markers is not a function of the media used (Supplemental Figure 7) .
Macrophage numbers correlate with β-catenin level, cellularity, and scar size in human wound repair. To determine the contribution of macrophages to wound healing in patients, we examined 10 human hypertrophic scars and 3 normal scars (ref. 46 and Supplemental Figure 8 ). The scar tissues were obtained from patients requiring revision surgery, and hypertrophic scars were characterized by the Vancouver Scar Scale (VSS). Hypertrophic scars are known to exhibit high levels of β-catenin, and their dermal layer is composed of fibroblasts that are similar to those observed during the proliferative phase of wound repair.
The wounds were stained for F4/80 + and β-catenin. There were 4 times the number of F4/80 + cells per high-powered field in the hypertrophic scar tissue (12.3% ± 2.4%) compared with the number seen in normal scars (4.0% ± 1.15%). The number of cells per high-powered field positively correlated with the number of β-catenin + (correlation coefficient = 0.87, 2-tailed probability = 0.026) and F4/80 + (correlation coefficient = 0.89, 2 tailed probability = 0.019) cells. Thus, the number of macrophage cells correlates with scar size and β-catenin levels in human wound repair. Increased numbers of macrophage cells in a wound may contribute to the development of a hyperplastic scar. Tcf signaling activation. By examining cells lacking β-catenin, we found a previously unidentified important function for β-catenin in myeloid lineage cells, that of regulating cell motility and adhesion, and this function is required for normal wound repair.
β-Catenin plays a critical role in regulating the number of macrophages present in the healing wound, and this is likely due to its regulation of cell motility and adhesion. This function of β-catenin is supported by in vitro studies correlating Wnt pathway target genes or β-catenin levels in macrophages with migration and mobilization in response to inflammation (42, 47) . β-catenin regulates the expression of genes involved in cell migration and adhesion, such as cadherins, catenins, ADAMs, and integrins, and this gene expression regulation is likely the mechanism by which β-catenin regulates cell motility and adhesion. The importance of macrophage motility and cell adhesion in wound repair is supported by data from mice lacking β2 integrin, in which defective macrophage cell adhesion is associated with poor wound repair (48) .
Several factors are known to activate β-catenin during wound healing. Wnt ligands, which activate β-catenin, are present during the earliest phases of wound healing (49) . Macrophages express multiple receptors for Wnt, and we identified several in our gene profiling studies (GEO GSE52163). Cytokines liberated early in wound repair can also activate β-catenin. In later phases of repair, extracellular matrix components can regulate β-catenin (50). The excreted factors liberated in early phases of wound healing likely activate β-catenin in macrophages, which in turn regulate the expression of genes that stimulate cell migration to the wound and enhance their adhesion in the region of healing tissues.
During wound healing, macrophages lacking β-catenin produce less TGF-β1 expression, and treatment with TGF-β1 partially restores normal wound healing in mice lacking β-catenin in macrophages. TGF-β is liberated by macrophages in the wound, and as such, the ability of these cells to migrate to and adhere in granulation tissue is likely responsible for the presence of TGF-β during healing. In support of this notion, macrophages from mice deficient in cd18, which also have impaired adhesion, show decreased TGF-β activity in vitro (48) . TGF-β and other cytokines released by macrophages in turn cause mesenchymal cells to populate the healing wound and attain a myofibroblast phenotype (48) . Much has been speculated about macrophage cell plasticity, and these 
Figure 7
Macrophages lacking β-catenin induce less TGF-β1 signaling, and TGF-β1 partially rescues the wound phenotype of mice lacking β-catenin in macrophages. (A) Quantitative RT-PCR analysis showing decreased TGF-β1 expression in β-catenin-deficient macrophages from Lysz-Cre Catnb tm2KEM ROSA-EYFP mice compared with that seen in their control littermates. (B) pSmad2 staining of fibroblasts that were exposed to either control (top panels) or β-catenin-deficient macrophages (bottom panels), indicating less pSmad2-positive cells in fibroblasts that were exposed to macrophages lacking β-catenin (quantified in C). Arrow shows pSmad2-positive cells. Scale bars: 100 μm. (D) Ki67 staining of fibroblasts that were exposed to either control macrophages (top panels) or to β-catenin-deficient macrophages (lower panels), indicating less Ki67-positive cells in fibroblasts that were exposed to macrophages lacking β-catenin (quantified in E). Arrow shows Ki67-positive cells. Scale bars: 200 μm. (F) Cell density quantification shows a significant increase in the number of cells in healing wounds in mice treated with TGF-β1 compared with those treated with vehicle. (G and H) Representative histology of a wound from a mouse treated with vehicle or TGF-β1 whose macrophages lacked β-catenin. Image in G is magnified in the lower panel; scale bars: 800 μm; 100 μm. Image in H is magnified in the lower panel; scale bars: 800 μm; 100 μm. Data represent the mean ± 95% CI of 7 mice. landmark for detecting the wound margin for measurement. Scar size was determined using histologic sections cut at a right angle to the skin surface across the healing wound. Serial sections were observed, and the section with the largest diameter at the center of the healing wound was selected for measurement of the broadest width of the wound. The area of the granulation tissue and the diameter of the wound were measured from the slides, and Meazure 2.0 software (C Thing Software) was used as an aid in measuring the wound diameter, in counting the number of granulation tissue cells, and in measuring the area of the granulation (or dermal) component of the healing wound. To semiquantitatively assess the degree of collagen deposition in the tissue, a modified Masson's trichrome procedure was used and quantified as previously reported (57) . Following mordant in Bouin's solution for 20 minutes at 56°C, sections were stained with phosphotungstic-phosphomolybdic acid for 5 minutes, aniline blue dye for 8 minutes, and 1% acetic acid for 2 minutes. The degree of blue staining (collagen deposition score) in the dermis layer was scored from 0 to 10 by 2 independent, blinded observers.
Isolation and culture of bone marrow-derived macrophages. Macrophages were isolated from the bone marrow as previously described (58) . Briefly, bone marrow was flushed using lymphocyte medium (RPMI-1640 plus 10% FBS plus 1% penicillin-streptomycin) supplemented with 20 mM HEPES. Cells were then seeded at a concentration of 2 × 10 6 cells/ml. Conditioned medium from L929 cells (CCL-1, macrophage medium; ATCC) was used to facilitate the growth of macrophages (58) .
Macrophage treatment of irradiated wounds. To study deficient wound repair, control mice were exposed to 2.6-Gy whole-body irradiation using a 137 Cs irradiator and were wounded 24 hours after irradiation. Cultured macrophages (10 5 cells) from donor mice of the various genotypes were mixed with 50 μl of Matrigel (BD Biosciences) and applied to wounds of recipient mice immediately after injury. RFP mice were provided by Andras Nagy (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada).
TGF-β1 treatment of the wounds. Recombinant TGF-β1 (500 ng; Sigma-Aldrich) was mixed with 50 μl Matrigel and applied to each wound in the recipient mice immediately after injury.
Immunohistochemical analysis. Histologic sections were analyzed using immunohistochemistry with antibodies against GFP (Rockland Inc.); F4/80 (Serotec); Mac1, FAP, α-SMA, and β-gal (all from Abcam); β-catenin, pSmad2, and Ki67 (all from Cell Signaling Technology); and involucrin and phalloidin (both from Invitrogen). The antibodies were detected using a biotinylated secondary antibody, and sections were counterstained using DAPI. Five high-powered fields were examined at identical intervals across the healing wound to count the number of cells with positive and negative staining for each sample. AxioVision software (Zeiss) was used to assist in the cell counting. LacZ expression was detected by incubating wound samples in 5-bromo-4-chloro-3-indolyl β-D-galactosidase staining solution according to a protocol obtained from Specialty Media (5). For human tissue staining (10 hypertrophic scar samples and 3 normal scars), we used the Betazoid DAB chromogen kit (Biocare Medical) according to the manufacturer's protocol. For quantifications, 5 high-powered fields were examined at identical intervals across the dermal components of scars to count the number of cells with positive and negative staining for each marker. Human scar tissues were provided by Marc G. Jeschke (Ross Tilley Burn Centre, Sunnybrook Health Science Center, Toronto, Canada).
Gene expression analysis. The healing wound was dissected from the unwounded tissue using microdissection. Healing wound tissue was homogenized, total RNA was extracted, and reverse transcription was performed to generate cDNA, which was analyzed using real-time PCR with specific primers purchased from Life Technologies (59) . To compare β-galpositive cell expression data with β-gal-negative cells, gene expression analysis was performed using Parktec Genotyping Suite and Ingenuity Systems cells can attain a fibroblast-like phenotype. Without β-catenin, macrophages are deficient in their ability to achieve this phenotype. In other cell types, migration is related to their ability to achieve a mesenchymal phenotype (8, 32, 42) . It is an intriguing possibility that the same notion is true for macrophages. Here, we showed that β-catenin is a critical regulator in macrophage motility and adhesion, and it is likely that adhesion is also required for the release of TGF-β during healing.
β-Catenin is also important in other cell types during healing, and some of this is independent of the role of β-catenin in macrophages. For instance, when only muscle progenitor cells are deficient in β-catenin, there is a smaller wound size (21) . When all cell types have lower levels of β-catenin, TGF-β will not cause a dramatic phenotypic rescue in wound repair, as we found when only macrophages were deficient in β-catenin. However, without β-catenin in macrophages, the initial phases of normal healing did not occur. Thus, while β-catenin plays a role in many cell types during repair, its role in the macrophages is essential to initiate the wound process.
In human wound healing, the level and duration of β-catenin activity correlates with wound size (51, 52) . In our examination of human wounds, we found that the number of macrophage cells correlates with β-catenin levels, wound cellularity, and scar size, showing the relevance of this pathway and cell type in patients. Several pharmacologic agents are under development that modulate β-catenin activity, and these could be used to treat pathologic wound repair processes. Interestingly, embryonic wounds heal without scarring during stages before the monocyte lineage develops (18) , and canonical Wnt signaling, which is active during postnatal healing, is less active in fetal cutaneous wound repair (53) . The contribution of Lysz-expressing progeny in wound repair identifies an abundant source of cells that have the potential to be used in patients with deficient wound repair, such as those with irradiated wounds or chronic wounds, and possibly in other repair processes.
Methods
Mice, wounding, and wound analysis. To drive Cre recombinase in Lyszexpressing cells, we used the Lysz-Cre (B6.129-Lysz tm1(cre)Ifo /J) (24) mouse, which expresses Cre recombinase driven by the endogenous Lysz regulatory elements. The ROSA-EYFP (B6.129X1-Gt[ROSA]26Sor tm1(EYFP)Cos /J) (54) mouse contains an EYFP gene inserted into the Gt(ROSA)26Sor locus. Expression of EYFP is inhibited by an upstream LoxP-flanked stop sequence. When bred into mice expressing a Cre recombinase, the stop sequence is deleted and EYFP is expressed. Catnb tm2KEM mice (55) possess LoxP sites flanking introns 1 and 6 of the gene encoding β-catenin, resulting in a null allele when exposed to Cre recombinase. Tcf reporter mice (5) contain a LacZ gene downstream of a c-fos minimal promoter and 3 consensus Tcf-binding motifs. To label cells from donor mice, we used a mouse that constitutively expresses RFP (56) . At least 6 mice were used in each group for each experiment (unless otherwise specified), and in experiments in which wound phenotypes were compared, we used a minimum of 8 mice in each group.
To generate full-thickness skin wounds, 3-month-old mice were anesthetized, and the dorsal skin was shaved. After sanitizing with 70% ethanol, 4 full-thickness wounds were created on the dorsal skin using 4-mmdiameter dermal biopsy punches (Miltex Inc.). Wound tissues were excised from mice 1 week after wounding or 4 weeks after wounding, fixed in 10% formalin overnight, and prepared for histologic analysis. To measure scar width, paraffin sections stained with trichrome were used. Intact dermis stains blue when using trichrome staining, since it is a collagen-rich area in comparison with newly formed granulation tissue. This makes a wounded area. The migratory abilities were quantified by measuring the total number of cells in the scratched regions as well as by measuring the distance between cells in the scratch zone.
Invasion assays were performed using a Boyden Chamber CytoSelect Cell Migration Assay kit with polycarbonate membrane inserts (5-μm pore size; Cell Biolabs Inc.). Bone marrow-derived macrophages (10 5 cells) were placed inside the insert containing macrophage-specific media. A coverslip pre-seeded with 10 5 control fibroblasts was placed at the bottom of the lower chamber. Macrophages were allowed to migrate for 6 hours before the upper chamber was removed. The total number of macrophages in the lower chamber (adhered and floating cells) was quantified, and the same approach was used in the experiment set up without fibroblasts in the lower chamber.
Statistics. Data are presented as the mean ± 95% CI, unless otherwise specified. A 2-tailed Student's t test and Pearson's correlation coefficient test were used for analysis. A P value less than 0.05 was considered statistically significant. To estimate the sample size for mouse studies, we performed a power calculation to determine the number of animals that would be needed in each group to detect a 25% difference in scar size based on the mean scar size and the variability from our previous studies (10, 21) . We calculated that 8 mice would be needed in each group to detect this difference.
Study approval. All procedures using animals were approved by the Sick Kids animal care committee (7014; March 19, 2009 ) under the auspices of the Canadian Council on Animal Care. Human tissue samples were obtained following provision of informed consent from the patients who were undergoing reconstructive burn surgery. The scar tissues were obtained (approval 194-2010) from patients requiring revision surgery, and hypertrophic scars were characterized by the VSS (61). Vascularity, pigmentation, pliability, and height were measured according to the VSS.
Software. RNA from these cell populations was analyzed using microarray. In addition, total RNA of bone marrow-derived macrophages from LyszCre Catnb tm2KEM mice and control macrophages from Catnb tm2KEM mice were extracted using a QIAGEN kit according to the manufacturer's instructions, and expression profiles were compared using microarray analysis.
For gene profile analysis, RNA quality was assessed with a Bioanalyzer (Agilent Technologies), and samples with an RNA integrity number (RIN) greater than 8.5 were included for array. cDNA was generated and hybridized onto the Affymetrix Mouse Gene 1.0 ST chips. Analysis of gene expression was performed using Parktec Genotyping Suite and Ingenuity Systems Software.
Flow cytometry. Microdissected healing wounds were used for cell analysis. Briefly, the scar was chopped into fine pieces, then transferred to a warmed collagenase cocktail (1X dispase, 0.05% trypsin, 1,000 U collagenase in high-glucose DMEM with 1% antibiotic-antimycotic). The collagenase cocktail with tissue was rotated at 37°C for up to 30 minutes. Halfway through incubation, the tissue was gently passed through a syringe with a 16-gauge needle to aid in breaking down the tissue. Once digested, the cocktail was filtered through a 100-μm filter, centrifuged for 5 minutes at 150 g, and the supernatant was removed. The cell pellet was resuspended in growth medium, counted, and separated equally into flow tubes. For flow cytometry of β-gal-positive cells, the dissociated cells were fixed and permeabilized using BD Cytofix/Cytoperm buffer for 20 minutes at room temperature. After washing, cells were resuspended in staining buffer containing FDG (60) substrate, which gives a green fluorescent product to cells expressing β-gal. MoFlow (Cytomation) with a 488-nm blue laser power set to 100 mW and FL1 with a 530/40 BP filter were used to select EYFP-expressing cells.
Adhesion assay. Fibroblasts were cultured at 15,000 cells/cm 2 for 4 days. 20,000 macrophages/cm 2 in 1 ml of media (10% FBS, DMEM, 1% penicillin-streptomycin) were added on the fourth day for 6 hours. The supernatant was collected, and the number of nonadherent macrophages was counted using a Beckman Z1 Coulter Particle counter. Particles between 10 to 20 μm in size were counted to eliminate any potentially detached fibroblasts.
Scanning electron microscopy. Scanning electron microscopy was used to examine the morphological characteristics of macrophages in adhesion assays. Cells were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.3). After washing in buffer, cells were dehydrated in a graded series of ethanol solutions. After critical-point drying (Bal-Tec CPD 030), the samples were sputtered with gold (Denton Desk II sputter coater), and the probes were examined by scanning electron microscopy (FEI XL30 ESEM; Philips). Macrophages from 3 β-catenin-deficient mice (Lyzs-Cre Catnb tm2KEM ROSA-EYFP) and 3 control (Lyzs-Cre ROSA-EYFP) mice were analyzed.
Migration and invasion assays. Bone marrow-derived monocytes were grown in macrophage-inducing medium to a confluence of 80% to 100% before the cell monolayer was scratched using a sterile micropipette tip. After washes with PBS, fresh macrophage-specific medium was added. The images of the wounded area were captured immediately after the scratch (t0) and 24 hours later (t24) to monitor macrophage migration into the
